Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1 - Concepedia

Concepedia

Publication | Open Access

Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1

DOI Full Paper Access

100

Citations

11

References

2019

Year

Filippo Montemurro, Antonio Antón, Rachel Wuerstlein, Suzette Delaloge, Jacques Bonneterre, Nathalie Quénel-Tueux, Sabine C. Linn, Natsumi Irahara, Margarita Donica, Nicolas Lindegger,

European Journal of Cancer

Tumor BiologyBreast OncologyMedicinePrimary ResultsPathologyBreast CancerCancer TreatmentOncologyCancer ResearchTrastuzumab Emtansine

References

	Year	Citations

Page 1

Page 1